 |
 |
|||
|
|
|||
|
 |
|
Vancouver Chapter Prior Event LES Vancouver Chapter Meeting The Vancouver chapter of the LICENSING EXECUTIVES SOCIETY invites all LES members and friends to a presentation on initiatives at the University of BC for new drug development, specifically therapies from stem cell research. The UBC Industry Liaison Office is the leading university technology transfer office in Canada for commercialization of biotechnology innovations. DATE: Thurs., Feb. 17, 2005. TIME: 12:00 to 1:30 Lunch, presentation, and questions. SPEAKERS: Angus Livingstone and Natalie Dakers SUBJECT: New international developments in pharmaceutical development and licensing at UBC. PLACE: McCarthy Tetrault,
Boardroom John Pearson, Host COST: $20 for LES members, $30 for non members. Please make cheques payable to the LES Vancouver Chapter, and send payment in advance to Lorraine Duke at the address below. PLEASE RSVP (with payment) no later than Tuesday, Feb. 15, 2005 to: Lorraine Duke, Assistant
to Hilton W.C. Sue Tel: 604-669-3432 ext. 8960 Fax: 604-681-4081 Email: lduke@patentable.com WHO SHOULD ATTEND: Professionals in with an interest in high technology licensing, technology transfer, and intellectual property administration. SPEAKER INFORMATION: ANGUS LIVINGSTONE: Angus Livingstone is the Managing Director of the University Industry Liaison Office (UILO) at The University of British Columbia, and is President of the University's wholly-owned subsidiary, UBC Research Enterprises Inc. The UILO conducts the technology transfer and commercialization at The University of British Columbia. The UILO's record in securing U.S. patents is unrivalled by any other Canadian university. UBC currently has over 200 licenses with companies around the world and has actively supported the creation of 115 spin-off companies. Since 1988, Angus' duties have included managing the intellectual property and research affiliations with UBC teaching hospitals, the national Networks of Centres of Excellence, and a wide variety of collaborative research projects and technology licenses with industry. Angus Livingstone is a Board Director of the national Stem Cell Network. SCN is a not-for-profit organization and one of Canada's 22 Networks of Centre of Excellence. It was established in 2001 to advance stem cells research in Canada. SCN plans to carry out a project to establish a new model for the commercialization of university and hospital stem cells research across Canada. NATALIE DAKERS: Natalie Dakers is Chief Executive Officer of the Centre for Drug Research & Development. CDRD is being developed to promote advanced drug development and training and enhance the commercialization of drugs discovered in BC's academic institutions. Natalie Dakers is past Chair of BC Biotech, and was recently President and Chief Executive Officer of Neuromed Technologies Inc., a private biopharmaceutical company. Prior to co-founding Neuromed, Ms. Dakers was a senior manager for life sciences technology transfer at the University Industry Liaison Office (UILO) at the University of BC. Natalie is the member of several Boards, including that of Genome BC.
|
 |
|
